FIELD: organic chemistry, genetics.
SUBSTANCE: invention refers to genetic engineering and can be applied for production of high-purity engineered insulin Lyspro that is immediate-action analogue of human insulin. Transformation of parent strain of bacteria Escherichia coli BL21 of plasmid DNA pLP-3-1 results in strain Escherichia coli BLP21-producer of proinsulin Lyspro. The invention enables to produce stable high yield recombinant insulin Lyspro and simplify production technology.
EFFECT: production of stable high yield recombinant insulin Lyspro and simplify production technology.
1 ex, 1 dwg
Authors
Dates
2008-05-27—Published
2006-11-21—Filed